Frontlight ResearchEarly access
Neuromyelitis optica (NMOSD) trials, also abroad
67 open Neuromyelitis optica (NMOSD) trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
The same trial often runs in several countries
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies has 3 sites in Germany and runs in 8 countries. If a site near you is full, another one may still take people.
See Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies in all 8 countries